Histopathological features of HER2 overexpression in uterine carcinosarcoma: proposal for requirements in HER2 testing for targeted therapy

导出原文传递

翻译打印收藏纠错

作者： Yoshida, Hiroshi ^[1] ; Nishikawa, Tadaaki ^[2] ; Matsumoto, Koji ^[3] ; Mori, Masahiko ^[4] ; Hirashima, Yasuyuki ^[5] ; Takehara, Kazuhiro ^[6] ; Ariyoshi, Kazuya ^[7] ; Hasegawa, Kosei ^[8] ; Yonemori, Kan

作者单位： Natl Canc Ctr, Dept Diagnost Pathol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan ^[1] Hyogo Canc Ctr, Div Med Oncol, Ambulatory Chemotherapy Ctr, Kitaoji Cho, Akashi, Hyogo, Japan ^[2] Aichi Canc Ctr Hosp, Dept Gynecol Oncol, Chikusa Ku, Nagoya, Aichi, Japan ^[3] Shizuoka Canc Ctr, Div Gynecol, Nagaizumi, Shizuoka, Japan ^[4] Natl Hosp Org Shikoku Canc Ctr, Dept Gynecol Oncol, Minamiumemoto Machi, Matsuyama, Ehime, Japan ^[5] Natl Hosp Org Kyushu Canc Ctr, Gynecol Serv, Minami Ku, Fukuoka, Japan ^[6] Natl Canc Ctr, Dept Breast & Med Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan ^[7] Saitama Med Univ Int Med Ctr, Dept Gynecol Oncol, Hidaka, Saitama, Japan ^[8]

关键词 Uterine carcinosarcoma HER2 Immunohistochemistry Scoring system Gastric cancer Breast cancer

发布时间 2021-10-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交